Yan Gao, MD, PhD^1*, Huiqiang Huang, MD, PhD², Xiaoxiao Wang^3*, Bing Bai^3*, Liling Zhang, MD, PhD^4*, Yin Xiao^4*, Xinxiu Liu^5*, Wenyu Li, PhD⁶, Wei Xu, MD, PhD⁷, Ru Feng⁸, Yu Chen^9*, Huijing Wu^10*, Jibin Li^11* and Xue Wu^12*

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
³Cancer Center of Sun Yat-sen University, Guangzhou, China
⁴Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Cancer Center, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
⁶Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
⁷Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁸Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
⁹Department of pathology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guanzhou, China
¹⁰Hubei Cancer Center, Wuhan, CHN
¹¹Department of Clinical Research, Sun Yat-sen University Cancer Center, Guanzhou, China
¹²Translational Medicine Research Institute, Geneseeq Technology Inc, Toronto, Canada

Swami P. Iyer, MD¹, Jie Xu, MD^2*, Melody R. Becnel, MD³, Ranjit Nair, MD^4*, Raphael Steiner, MD^5*, Lei Feng, MS^6*, Hun Ju Lee, MD³, Paolo Strati, MD⁷, Sairah Ahmed, MD⁸, Simrit Parmar, M.D., MSCI⁹, Yago Nieto, MD¹⁰, Chitra Hosing, MD¹¹, Jason Westin, MD³, Loretta J. Nastoupil, MD¹², Ann Vo^13*, Felipe Samaniego, MD³, Nathan H. Fowler, MD¹², Neeraj Saini, MD¹⁴, Issa F. Khouri, MD¹¹, Jin S. Im¹⁴, Preetesh Jain, MBBS, MD, DM, PhD³, Luis Fayad¹⁵, Michael Wang, MD¹⁶, Roberto N. Miranda, MD^2*, Francisco Vega, MD, PhD¹⁷, Christopher Flowers, MD, MS¹⁵ and Sattva S. Neelapu, MD³

¹UT MDANDERSON, Houston, TX
²Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵MD Anderson Cancer Center, Houston, TX
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
⁸Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
¹¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²The University of Texas MD Anderson Cancer Center, Houston, TX
¹³University of Texas MD Anderson, Houston, TX
¹⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹⁶Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX
¹⁷Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX

Steven M. Horwitz, MD¹, James M. Foran, MD², Michael Maris, MD^3,4, Ahmed Sawas, MD⁵, Craig Okada, MD, PhD⁶, Tatyana A. Feldman, MD⁷, Mark D. Minden⁸, Lubomir Sokol, MD, PhD⁹, Matthew Mei, MD¹⁰, Ian W. Flinn, MD, PhD^11,12, Diego Villa, MD MPH¹³, Mary-Elizabeth M. Percival, MD^14,15, Deepa Jagadeesh, MD, MPH¹⁶, Kerry J. Savage, MD MSc¹³, Oleg E. Akilov, MD, PhD^17*, Catherine Diefenbach, MD¹⁸, Youn H. Kim, MD¹⁹, Gloria H. Y. Lin, PhD^20*, Tina Catalano, MSc^20*, Penka S. Petrova, PhD^20*, Bob Uger, PhD^20*, Naomi Molloy, BSc^20*, Kathleen Large, RN, MSN^20*, Yaping Shou, MD, PhD²⁰ and Stephen M. Ansell, MD, PhD²¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
³Colorado Blood Cancer Institute, Denver, CO
⁴Sarah Cannon Research Institute, Denver, CO
⁵Center for Lymphoid Malignancies, Columbia University Irving Medical Center, New York, NY
⁶Oregon Health and Science University, Portland, OR
⁷Hackensack University Medical Center, NY, NY
⁸Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
⁹Moffitt Cancer Center, Tampa, FL
¹⁰City of Hope National Medical Center, Duarte, CA
¹¹Sarah Cannon Research Institute, Nashville, TN
¹²Tennessee Oncology, Nashville, TN
¹³British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁵Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
¹⁶Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Solon, OH
¹⁷University of Pittsburgh Medical Center, Pittsburgh, PA
¹⁸Perlmutter Cancer Center at NYU Langone Health, New York, NY
¹⁹Department of Dermatology, Stanford University School of Medicine, Stanford, CA
²⁰Trillium Therapeutics Inc., Mississauga, ON, Canada
²¹Mayo Clinic, Rochester, MN